Officer sold
~$2MReported value · 23K sh @ $86.4201
Stock since the trade -1.5% · S&P 500 +1.8% · to Oct 1
Edwards Lifesciences's CVP,Strategy/Corp Development sold $2M of Edwards Lifesciences shares. Nobody planned it ahead of time.
Loading…
CVP,Strategy/Corp Development
Disclosures on record
30
Companies involved
1
Stock since the trade -1.5% · S&P 500 +1.8% · to Oct 1
Edwards Lifesciences's CVP,Strategy/Corp Development sold $2M of Edwards Lifesciences shares. Nobody planned it ahead of time.
Stock since the trade +4.7% · S&P 500 +3.4% · to Oct 1
Edwards Lifesciences's CVP,Strategy/Corp Development sold $818K of Edwards Lifesciences shares. Nobody planned it ahead of time.
Stock since the trade +4.7% · S&P 500 +3.4% · to Oct 1
Edwards Lifesciences's CVP,Strategy/Corp Development sold $655K of Edwards Lifesciences shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Officer sold ~$1.44M of Edwards Lifesciences
Scheduled in advanceOfficer sold ~$377K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$974K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Stock since the trade +2.1% · S&P 500 +10.2% · to Oct 1
Edwards Lifesciences's CVP,Strategy/Corp Development sold $2.01M of Edwards Lifesciences shares. Nobody planned it ahead of time.
Officer sold ~$749K of Edwards Lifesciences
Scheduled in advanceOfficer sold ~$223K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Stock since the trade +2.5% · S&P 500 +12.1% · to Oct 1
Edwards Lifesciences's CVP,Strategy/Corp Development sold $494K of Edwards Lifesciences shares. Nobody planned it ahead of time.
Stock since the trade +2.5% · S&P 500 +12.1% · to Oct 1
Edwards Lifesciences's CVP,Strategy/Corp Development sold $460K of Edwards Lifesciences shares. Nobody planned it ahead of time.
Gift or transfer — classified separately from trades.
Officer sold ~$951K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.